Ticker AGIO – Agios Pharm – sales, description, marketcap – Tickerday.com

AGIO

Agios Pharm

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 2.40B; Volume: 139.36K; AvgVol 3m: 588.32K; Beta: 1.84;

Cost estimate:

P/E: –; EPS: -5.30; EPS growth quarter/prev quarter: 29.90%;

EPS growth this year: -13.80%; EPS growth past 5 years: -34.00%;

EPS ttm: -5.30;

P/S: 13.82; P/B: 4.39; P/Cashflow: 3.25; P/FCF: ;

Sales: 185.91M; Sales growth quarter/prev quarter: 42.40%; Sales growth past 5 years: 12.50%;

Profitability:

Gross Margin: 99.00%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -40.30%; ROE – return on equity: -59.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.20%; Insider Transactions:-2.58%;

Institutional Ownership: 99.60%; Institutional Transactions: -2.01%;

Data update: 07.10.2020.